{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:38Z","timestamp":1786119398599,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,4,27]]},"DOI":"10.1097\/tp.0b013e3181ccd7f2","type":"journal-article","created":{"date-parts":[[2010,3,24]],"date-time":"2010-03-24T04:12:22Z","timestamp":1269403942000},"page":"994-1000","source":"Crossref","is-referenced-by-count":41,"title":["Interaction Between Everolimus and Tacrolimus in Renal Transplant Recipients: A Pharmacokinetic Controlled Trial"],"prefix":"10.1097","volume":"89","author":[{"given":"Julio","family":"Pascual","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domingo","family":"del Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Cabello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Pallard\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep M.","family":"Griny\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merc\u00e8","family":"Brunet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210129","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"R2-12-20210129","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1681\/ASN.2005050463","article-title":"Chronic renal allograft dysfunction.","volume":"16","author":"Chapman","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R3-12-20210129","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0955-470X(05)80003-5","article-title":"Calcineurin inhibitors and chronic renal allograft dysfunction: Not enough or too much?","volume":"15","author":"Paul","year":"2001","journal-title":"Transplant Rev"},{"key":"R4-12-20210129","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/01.TP.0000128636.70499.6E","article-title":"Calcineurin inhibitor nephrotoxicity: Longitudinal assessment by protocol histology.","volume":"78","author":"Nankivell","year":"2004","journal-title":"Transplantation"},{"key":"R5-12-20210129","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00007890-199707150-00008","article-title":"SDZ RAD, a new rapamycin derivative. Pharmacological properties in vitro and in vivo.","volume":"64","author":"Schuler","year":"1997","journal-title":"Transplantation"},{"key":"R6-12-20210129","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1097\/00007890-199712270-00039","article-title":"Tacrolimus (TAC506) and sirolimus (rapamycin) in combination are not antagonistic but produce extended graft survival in cardiac transplantation in the rat.","volume":"64","author":"Vu","year":"1997","journal-title":"Transplantation"},{"key":"R7-12-20210129","first-page":"893","article-title":"Pharmacokinetics and tolerability of tacrolimus and sirolimus combination therapy in stable renal transplant recipients [abstract].","volume":"12","author":"Hariharan","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R8-12-20210129","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00075200-200212000-00010","article-title":"Everolimus in renal transplantation.","volume":"7","author":"Srinivas","year":"2002","journal-title":"Curr Opin Organ Transpl"},{"key":"R9-12-20210129","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/ndt\/18.3.491","article-title":"Kidney function and morphology after short-term combination therapy with cyclosporine A, tacrolimus and sirolimus in the rat.","volume":"18","author":"Nielsen","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"R10-12-20210129","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/FTD.0b013e318198d092","article-title":"Opportunities to optimize tacrolimus therapy: Report of the European Consensus Conference.","volume":"31","author":"Wallemacq","year":"2009","journal-title":"Ther Drug Monit"},{"key":"R11-12-20210129","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/bdd.524","article-title":"Everolimus drug interactions: Application of a classification system for a clinical decision making.","volume":"27","author":"Kovarik","year":"2006","journal-title":"Biopharm Drug Dispos"},{"key":"R12-12-20210129","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.clpt.2003.11.374","article-title":"Tacrolimus therapy according to mucosal MDR1 levels in small-bowel transplant recipients.","volume":"75","author":"Masuda","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"R13-12-20210129","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00008571-200208000-00005","article-title":"C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation.","volume":"12","author":"Goto","year":"2002","journal-title":"Pharmacogenetics"},{"key":"R14-12-20210129","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1600-6143.2004.00411.x","article-title":"Pharmacokinetics of sirolimus and tacrolimus in pediatric transplant patients.","volume":"4","author":"Schubert","year":"2004","journal-title":"Am J Transplant"},{"key":"R15-12-20210129","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1111\/j.1600-6143.2005.00963.x","article-title":"Adding sirolimus to tacrolimus-based immunosuppression in pediatric renal transplant recipients reduces tacrolimus exposure.","volume":"5","author":"Filler","year":"2005","journal-title":"Am J Transplant"},{"key":"R16-12-20210129","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/00007691-200206000-00004","article-title":"A clinical pharmacokinetic study of tacrolimus and sirolimus combination immunosuppression comparing simultaneous to separated administration.","volume":"24","author":"McAlister","year":"2002","journal-title":"Ther Drug Monit"},{"key":"R17-12-20210129","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.phrs.2006.04.006","article-title":"Co-administration of sirolimus alters tacrolimus pharmacokinetics in a dose-dependent manner in adult renal transplant recipients.","volume":"54","author":"Baldan","year":"2006","journal-title":"Pharmacol Res"},{"key":"R18-12-20210129","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/01.TP.0000062837.99400.60","article-title":"Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: Results at 6 months.","volume":"75","author":"Gonwa","year":"2003","journal-title":"Transplantation"},{"key":"R20-12-20210129","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology.","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int"},{"key":"R21-12-20210129","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1034\/j.1600-6143.2003.00072.x","article-title":"Antibody-mediated rejection criteria\u2014An addition to the Banff 97 classification of renal allograft rejection.","volume":"3","author":"Racusen","year":"2003","journal-title":"Am J Transplant"},{"key":"R22-12-20210129","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1016\/j.transproceed.2006.10.092","article-title":"Differential pharmacokinetic interaction of TAC and cyclosporine on EVL.","volume":"38","author":"Kovarik","year":"2006","journal-title":"Transplant Proc"},{"key":"R23-12-20210129","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-6143.2004.00638.x","article-title":"Minimization of immunosuppressive therapy after renal transplantation: Results of a randomized controlled trial.","volume":"5","author":"Vanrenterghem","year":"2005","journal-title":"Am J Transplant"},{"key":"R24-12-20210129","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1097\/01.TP.0000162434.62591.F3","article-title":"Concentration-controlled everolimus (Certican): Combination with reduced-dose calcineurin inhibitors.","volume":"79","author":"Pascual","year":"2005","journal-title":"Transplantation"},{"key":"R25-12-20210129","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/TP.0b013e318166927b","article-title":"Multicenter, randomized study of the use of everolimus with tacrolimus after renal transplantation demonstrates its effectiveness.","volume":"85","author":"Chan","year":"2008","journal-title":"Transplantation"},{"key":"R26-12-20210129","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1097\/00007890-200105270-00008","article-title":"RAD in the novo renal transplantation: Comparison of three doses on the incidence and severity of acute rejection.","volume":"71","author":"Kahan","year":"2001","journal-title":"Transplantation"},{"key":"R27-12-20210129","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2165\/00003495-200464080-00005","article-title":"Everolimus.","volume":"64","author":"Chapman","year":"2004","journal-title":"Drugs"},{"key":"R28-12-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trre.2005.10.005","article-title":"Everolimus (Certican) in renal transplantation: A review of clinical trial data, current usage and future directions.","volume":"20","author":"Pascual","year":"2006","journal-title":"Transplant Rev"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0b013e3181ccd7f2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:13:04Z","timestamp":1786039984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-201004270-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,27]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e3181ccd7f2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.3201956.2888054","asserted-by":"object"}]},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4,27]]}}}